Eaton Vance Management Sells 6,067 Shares of West Pharmaceutical Services Inc. (WST)

Eaton Vance Management lowered its stake in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 2.2% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 265,858 shares of the medical instruments supplier’s stock after selling 6,067 shares during the period. Eaton Vance Management’s holdings in West Pharmaceutical Services were worth $32,825,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. grew its position in shares of West Pharmaceutical Services by 1.1% during the 3rd quarter. BlackRock Inc. now owns 6,640,595 shares of the medical instruments supplier’s stock valued at $819,914,000 after acquiring an additional 69,813 shares during the period. Franklin Resources Inc. boosted its holdings in West Pharmaceutical Services by 2.7% in the 3rd quarter. Franklin Resources Inc. now owns 4,837,831 shares of the medical instruments supplier’s stock worth $597,316,000 after buying an additional 126,760 shares during the last quarter. WCM Investment Management CA boosted its holdings in West Pharmaceutical Services by 51.2% in the 3rd quarter. WCM Investment Management CA now owns 1,036,034 shares of the medical instruments supplier’s stock worth $127,919,000 after buying an additional 350,614 shares during the last quarter. Bessemer Group Inc. boosted its holdings in West Pharmaceutical Services by 0.8% in the 3rd quarter. Bessemer Group Inc. now owns 958,737 shares of the medical instruments supplier’s stock worth $118,375,000 after buying an additional 7,921 shares during the last quarter. Finally, Janus Henderson Group PLC boosted its holdings in West Pharmaceutical Services by 27.1% in the 2nd quarter. Janus Henderson Group PLC now owns 875,723 shares of the medical instruments supplier’s stock worth $86,951,000 after buying an additional 186,752 shares during the last quarter. Institutional investors and hedge funds own 92.62% of the company’s stock.

WST stock opened at $109.56 on Monday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 2.23 and a current ratio of 2.94. West Pharmaceutical Services Inc. has a 12-month low of $82.74 and a 12-month high of $125.09. The stock has a market capitalization of $8.12 billion, a P/E ratio of 39.41, a PEG ratio of 4.10 and a beta of 1.19.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings data on Thursday, October 25th. The medical instruments supplier reported $0.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.70 by $0.06. West Pharmaceutical Services had a return on equity of 15.78% and a net margin of 9.06%. The company had revenue of $431.70 million for the quarter, compared to analysts’ expectations of $427.55 million. As a group, analysts expect that West Pharmaceutical Services Inc. will post 2.83 earnings per share for the current year.

Several equities research analysts recently issued reports on the company. Zacks Investment Research cut West Pharmaceutical Services from a “buy” rating to a “hold” rating in a report on Friday, August 10th. ValuEngine upgraded West Pharmaceutical Services from a “hold” rating to a “buy” rating in a report on Wednesday, October 17th.

ILLEGAL ACTIVITY NOTICE: “Eaton Vance Management Sells 6,067 Shares of West Pharmaceutical Services Inc. (WST)” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at https://www.com-unik.info/2018/12/03/eaton-vance-management-sells-6067-shares-of-west-pharmaceutical-services-inc-wst.html.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Read More: Systematic Risk

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit